O

OptiNose Inc
D

OPTN

0
USD
0.00
(0.00%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
0
حجم السوق
0
المقالات
المزيد

العنوان: OptiNose Inc

القطاع: Healthcare
الصناعة: Biotechnology
Option Therapeutics Inc is a clinical-stage company developing inventive drug therapies to treat debilitating and life-threatening liver disease through its investigational drug candidate BIV201 (continuous infusion terlipressin). BIV201 is administered as a patent-pending liquid formulation of terlipressin with patents issued, to date, in the U.S., China, Japan, Chile, and India.